Replies to post #406067 on Amarin Corp Plc (AMRN)

[couldbebetter]

Nobody cares because BP does not own it! If Denner is able to interest BP enough to
do a BO then maybe BP will turn it around. Back when JL used to say that Vascepa
would be flying off the shelves with good results I used to say that "education" was
the key. Unfortunately, the entire narrative around EPA has been tainted by pre-
conceived notions and the lack of any final authority on the subject. Perhaps
once a BP owns AMRN they could get the FDA to remove ineffective Omega-3's
such as generic & brand name Lovaza (as well as OTC fish oil products.) At a
minimum the FDA could put out some kind of guidance on all this. Amarin could
never do this, but I bet Pfizer could if they wanted to.